[The in vivo binding of a quaternary derivative of scopolamine (cimetropium bromide) to muscarinic receptors in the intestinal mucosa, after oral administration?].
D000284:Administration, Oral; D000818:Animals; D007413:Intestinal Mucosa / Q000187:drug effects / Q000378:metabolism; D008297:Male; D010276:Parasympatholytics / Q000008:administration & dosage / Q000378:metabolism*; D051381:Rats; D011976:Receptors, Muscarinic / Q000187:drug effects; D012602:Scopolamine Derivatives / Q000008:administration & dosage / Q000378:metabolism*
D010276:Parasympatholytics; D011976:Receptors, Muscarinic; D012602:Scopolamine Derivatives; C016859:cimetropium
Studi di binding in vivo ai recettori muscarinici del muscolo liscio intestinale, di un derivato quaternario della scopolamina (bromuro di cimetropio), somministrato oralmente.